Mechanisms and therapeutic implications of gsk-3 in treating neurodegeneration

Keyphrases

• Adequate Therapy 25%
• Autophagy 25%
• Cognitive Function 25%
• Common Target 25%
• Cytoskeleton Organization 25%
• Disease Pathogenesis 25%
• Effective Treatment 25%
• Glycogen Synthase Kinase 3 (GSK3) 100%
• Glycogen Synthase kinase-3 Inhibitors 25%
• Mammalian Target of Rapamycin (mTOR) 25%
• Mitochondria 25%
• Neurodegeneration 100%
• Neurodegenerative Diseases 75%
• Neuron Viability 25%
• Public Health 25%
• Targeted Control 25%
• Therapeutic Implications 100%
• Therapeutic Intervention 25%

Medicine and Dentistry

• Autophagy 33%
• Cognitive Function 33%
• Cytoskeleton 33%
• Deterioration 33%
• Disease 33%
• Diseases 33%
• Glycogen Synthase Kinase 3 100%
• Glycogen Synthase Kinase 3 Inhibitor 33%
• Mechanistic Target of Rapamycin 33%
• Mitochondrion 33%
• Neurodegeneration 100%
• Neurodegenerative Disorder 100%
• Public Health 33%

Neuroscience

• Autophagy 33%
• Behavior (Neuroscience) 33%
• Cognitive Function 33%
• Cytoskeleton 33%
• Glycogen Synthase Kinase 3 100%
• Glycogen Synthase Kinase 3 Inhibitor 33%
• Mammalian Target of Rapamycin 33%
• Mitochondrion 33%
• Neurodegeneration 100%
• Neurodegenerative Disorder 100%